Docality.com Logo
 
Dr. Sam  Yee  Md image

Dr. Sam Yee Md

215 Rockaway Tpke
Lawrence NY 11559
516 745-5024
Medical School: State University Of New York At Stony Brook, School Of Medicine - 1990
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: Yes
Participates In EHR: Yes
License #: 189920
NPI: 1093796484
Taxonomy Codes:
208100000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:99306 Description:Nursing facility care init Average Price:$450.00 Average Price Allowed
By Medicare:
$178.14
HCPCS Code:99309 Description:Nursing fac care subseq Average Price:$301.93 Average Price Allowed
By Medicare:
$96.25
HCPCS Code:99308 Description:Nursing fac care subseq Average Price:$255.68 Average Price Allowed
By Medicare:
$73.40
HCPCS Code:99305 Description:Nursing facility care init Average Price:$300.00 Average Price Allowed
By Medicare:
$140.98
HCPCS Code:99203 Description:Office/outpatient visit new Average Price:$181.97 Average Price Allowed
By Medicare:
$119.36
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$125.33 Average Price Allowed
By Medicare:
$79.85
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$157.39 Average Price Allowed
By Medicare:
$117.86
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$220.06 Average Price Allowed
By Medicare:
$181.85
HCPCS Code:97110 Description:Therapeutic exercises Average Price:$36.23 Average Price Allowed
By Medicare:
$31.07
HCPCS Code:G0283 Description:Elec stim other than wound Average Price:$14.85 Average Price Allowed
By Medicare:
$13.53
HCPCS Code:97530 Description:Therapeutic activities Average Price:$34.96 Average Price Allowed
By Medicare:
$34.75

HCPCS Code Definitions

97110
Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility
97530
Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes
99203
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face with the patient and/or family.
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99305
Initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 35 minutes are spent at the bedside and on the patient's facility floor or unit.
99306
Initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 45 minutes are spent at the bedside and on the patient's facility floor or unit.
99308
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 15 minutes are spent at the bedside and on the patient's facility floor or unit.
99309
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient has developed a significant complication or a significant new problem. Typically, 25 minutes are spent at the bedside and on the patient's facility floor or unit.
G0283
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1902981947
Internal Medicine
4,560
1578544276
Internal Medicine
4,177
1679545727
Internal Medicine
3,509
1235214271
Internal Medicine
3,242
1700820818
Internal Medicine
2,395
1144210196
Internal Medicine
1,983
1790766970
Internal Medicine
1,267
1184657959
Infectious Disease
1,263
1285615120
Family Practice
1,082
1164400156
Endocrinology
898
*These referrals represent the top 10 that Dr. Yee has made to other doctors

Publications

Novel MDM2 splice variants identified from oral squamous cell carcinoma. - Oral oncology
The presence of a variety of MDM2 splice variants has been reported in a range of different tumor types and is associated with poor patient prognosis. Furthermore, several MDM2 variants have been shown to have oncogenic properties. Despite this, MDM2 splice variants have not been comprehensively characterized in oral squamous cell carcinoma (OSCC).MDM2 splice variants were identified by polymerase chain reaction (PCR), using cDNA from 55 OSCC and 20 normal oral mucosa (NOM) tissues. MDM2 amplicons from the polymerase chain reactions were cloned and sequenced. The associations between the presence of MDM2 splice variants as well as the types of MDM2 splice variants with OSCC and patient clinico-pathological data was examined using Fisher Exact and Chi-square tests.Thirty-eight MDM2 splice variants were identified from both OSCC and NOM tissues, where the majority (30/38) were exclusively detected in OSCC. Some of these variants were similar to those reported in other cancers whilst 14 novel MDM2 splice variants predicted to code for proteins were also identified. The majority of these variants retained their RING binding domain but had lost the p53 binding site. The presence of MDM2 splice variants was significantly associated with OSCC and increased the risk of OSCC development (OR=9.98; 95% CI=2.94-33.90).MDM2 splice variants were identified in OSCC at a high frequency and were significantly associated with OSCC development. This suggests that MDM2 splice variants may play an important role in oral carcinogenesis and the functional role of these variants in OSCC should be examined further.Copyright © 2012 Elsevier Ltd. All rights reserved.
Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. - Oncotarget
Emerging biological and translational insights from large sequencing efforts underscore the need for genetically-relevant cell lines to study the relationships between genomic alterations of tumors, and therapeutic dependencies. Here, we report a detailed characterization of a novel panel of clinically annotated oral squamous cell carcinoma (OSCC) cell lines, derived from patients with diverse ethnicity and risk habits. Molecular analysis by RNAseq and copy number alterations (CNA) identified that the cell lines harbour CNA that have been previously reported in OSCC, for example focal amplications in 3q, 7p, 8q, 11q, 20q and deletions in 3p, 5q, 8p, 18q. Similarly, our analysis identified the same cohort of frequently mutated genes previously reported in OSCC including TP53, CDKN2A, EPHA2, FAT1, NOTCH1, CASP8 and PIK3CA. Notably, we identified mutations (MLL4, USP9X, ARID2) in cell lines derived from betel quid users that may be associated with this specific risk factor. Gene expression profiles of the ORL lines also aligned with those reported for OSCC. By focusing on those gene expression signatures that are predictive of chemotherapeutic response, we observed that the ORL lines broadly clustered into three groups (cell cycle, xenobiotic metabolism, others). The ORL lines noted to be enriched in cell cycle genes responded preferentially to the CDK1 inhibitor RO3306, by MTT cell viability assay. Overall, our in-depth characterization of clinically annotated ORL lines provides new insight into the molecular alterations synonymous with OSCC, which can facilitate in the identification of biomarkers that can be used to guide diagnosis, prognosis, and treatment of OSCC.

Map & Directions

215 Rockaway Tpke Lawrence, NY 11559
View Directions In Google Maps

Nearby Doctors

144 Harborview S
Lawrence, NY 11559
516 712-2929
57 Harborview W
Lawrence, NY 11559
516 393-3005
275 Rockaway Tpke
Lawrence, NY 11559
516 712-2225
14 Meadow Ln
Lawrence, NY 11559
516 391-1641
215 Rockaway Tpke
Lawrence, NY 11559
516 745-5024
176 Broadway
Lawrence, NY 11559
516 393-3333
141 Washington Ave Suite 200
Lawrence, NY 11559
917 931-1654
9 Copperbeech Ln
Lawrence, NY 11559
516 953-3292
279 Burnside Ave
Lawrence, NY 11559
516 715-5027
290 Central Ave 215
Lawrence, NY 11559
516 394-4488